Dinesh V Ph D Patel Protagonist Therapeutics, Inc (PTGX) insider trading activity

Dinesh V Ph D Patel is President and CEO of Protagonist Therapeutics, Inc. Currently has a direct ownership of 520,603 shares of PTGX, which is worth approximately $28.7 Million. The most recent transaction as insider was on Jul 25, 2025, when has been sold 10,415 shares (Common Stock) at a price of $54.78 per share, resulting in proceeds of $570,533. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 521K

7.74% 3M change

1.2% 12M change

Total Value Held $28.7 Million

DINESH V PH D PATEL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 25 2025	SELL Open market or private sale	$570,533 $54.78 p/Share	10,415 Reduced 1.96%	520,603 Common Stock
Jul 23 2025	SELL Open market or private sale	$959,920 $54.79 p/Share	17,520 Reduced 3.19%	531,018 Common Stock
Jul 22 2025	SELL Open market or private sale	$1,214,678 $55.05 p/Share	22,065 Reduced 3.87%	548,538 Common Stock
Jul 21 2025	SELL Open market or private sale	$705,444 $54.86 p/Share	12,859 Reduced 2.2%	570,603 Common Stock
Jul 21 2025	BUY Grant, award, or other acquisition	-	25,000 Added 4.11%	583,462 Common Stock
Jul 16 2025	SELL Bona fide gift	-	5,000 Reduced 0.89%	558,462 Common Stock
Jun 16 2025	SELL Bona fide gift	-	685 Reduced 0.12%	562,905 Common Stock
Jun 13 2025	SELL Bona fide gift	-	670 Reduced 0.12%	563,590 Common Stock
Mar 05 2025	BUY Exercise of conversion of derivative security	$101,040 $4.21 p/Share	24,000 Added 4.08%	564,260 Common Stock
Feb 19 2025	SELL Open market or private sale	$204,606 $38.18 p/Share	5,359 Reduced 0.98%	540,260 Common Stock
Jan 15 2025	SELL Payment of exercise price or tax liability	-	12,636 Reduced 2.26%	545,619 Common Stock
Jan 02 2025	BUY Grant, award, or other acquisition	-	149,800 Added 21.16%	558,255 Common Stock
Nov 26 2024	SELL Open market or private sale	$993,450 $46.25 p/Share	21,480 Reduced 5.0%	408,455 Common Stock
Nov 25 2024	SELL Bona fide gift	-	7,000 Reduced 1.61%	428,208 Common Stock
Nov 25 2024	SELL Open market or private sale	$3,687,299 $46.96 p/Share	78,520 Reduced 15.28%	435,208 Common Stock
Nov 25 2024	BUY Exercise of conversion of derivative security	$37,268 $21.58 p/Share	1,727 Added 0.4%	429,935 Common Stock
Nov 19 2024	SELL Bona fide gift	-	1,000 Reduced 0.19%	513,415 Common Stock
Jun 13 2024	SELL Bona fide gift	-	1,000 Reduced 0.19%	514,415 Common Stock
Jun 07 2024	SELL Open market or private sale	$1,231,650 $35.19 p/Share	35,000 Reduced 6.36%	515,415 Common Stock
Apr 01 2024	SELL Open market or private sale	$707,750 $28.31 p/Share	25,000 Reduced 4.35%	549,590 Common Stock
Mar 01 2024	SELL Open market or private sale	$948,600 $31.62 p/Share	30,000 Reduced 4.96%	574,590 Common Stock
Feb 26 2024	SELL Payment of exercise price or tax liability	$322,319 $29.53 p/Share	10,915 Reduced 1.77%	604,590 Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$104,930 $28.23 p/Share	3,717 Reduced 0.6%	615,505 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	84,875 Added 12.05%	619,222 Common Stock
Dec 13 2023	SELL Open market or private sale	$1,505,999 $20.08 p/Share	75,000 Reduced 12.31%	534,347 Common Stock

DVP

Dinesh V Ph D Patel

President and CEO

Newark, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTGX shares.

Notify only if

Value

Insider Trading

Get notified when an Protagonist Therapeutics, Inc insider buys or sells PTGX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Protagonist Therapeutics, Inc

Track Activities on PTGX

Account